{"nct_id":"NCT05911295","title":"Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-09-22","start_date_type":"ACTUAL","primary_completion_date":"2026-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}